scemblix
novartis europharm limited - asciminib hydrochloride - leucemie, mielogenă, cronică, bcr-abl pozitivă - agenți antineoplazici - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
scemblix 20 mg
novartis pharma gmbh - germania - asciminibum - compr. film. - 20mg - inhibitori de protein-kinaza
scemblix 40 mg
novartis pharma gmbh - germania - asciminibum - compr. film. - 40mg - inhibitori de protein-kinaza
acid acetilsalicilic comprimate 500 mg
upm din borisov sad - acid acetylsalicylicum - comprimate - 500 mg
ibuprofen comprimate filmate 200 mg
upm din borisov sad - ibuprofenum - comprimate filmate - 200 mg
vitaprofen capsule 200 mg
vitapharm-com srl, im - ibuprofenum - capsule - 200 mg
diclofenac gel 1%
farmaprim srl - diclofenacum - gel - 1%
diclofenac gel 1%
farmaprim srl - diclofenacum - gel - 1%
diclofenac de sodiu unguent 10 mg/g
upm din borisov sad - diclofenacum - unguent - 10 mg/g
nisit comprimate 100 mg
lekpharm srl - nimesulidum - comprimate - 100 mg